Behboodi, P., Grisi, J. D. P., Madrid, A., Salas, M., Castano, A., Kobbe, R., Alberca, C., Tariq, M., Rigo, M., Sarkar, R., Sucheston-Campbell, L., Chow, K., Hillengass, J., Slade, M., Parekh, S. S., Laganà, A., Biran, N., Siegel, D. S. D., Feinman, R., Tycko, B. (2026). <i>MACROD2</i>
                    and
                    <i>CDKN2A</i>
                    in multiple myeloma: Insights to germline susceptibility and cytogenetic risk from long-read Nanopore sequencing.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e19566